Nicox S.A. (EPA:ALCOX)
0.395
-0.009 (-2.23%)
Apr 28, 2026, 5:35 PM CET
Nicox Employees
Nicox had 5 employees as of December 31, 2024. The number of employees decreased by 23 or -82.14% compared to the previous year.
Employees
5
Change
-23
Growth
-82.14%
Revenue / Employee
€663,164
Profits / Employee
€5,412,303
Market Cap
34.81M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| THX Pharma Société Anonyme | 10 |
| Fermentalg | 63 |
| genOway Société anonyme | 148 |
| GenSight Biologics | 13 |
| OSE Immunotherapeutics | 64 |
| Advicenne | 13 |
| Aelis Farma | 24 |
| Valerio Therapeutics Société anonyme | 25 |
Nicox News
- 1 year ago - Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights - GlobeNewsWire
- 1 year ago - Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results - GlobeNewsWire
- 1 year ago - Nicox Provides Second Quarter 2024 Update - GlobeNewsWire
- 2 years ago - Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results - GlobeNewsWire
- 2 years ago - Nicox Provides Fourth Quarter 2023 Financial and Business Highlights - GlobeNewsWire
- 2 years ago - Nicox Provides First Half 2023 and Third Quarter 2023 Financial Results and Updates Key Milestones - GlobeNewsWire
- 3 years ago - Nicox Provides Second Quarter 2023 Financial and Business Highlights - GlobeNewsWire
- 3 years ago - Nicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design Data and Additional Subset Analysis Showing Superiority over Latanoprost at the World Glaucoma Congress - GlobeNewsWire